Cargando…
Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma
The aim of this study was to investigate whether the third-generation nitrogen-containing bisphosphonate (YM529) can inhibit the progression of established bone renal cell carcinoma (RCC) and to elucidate its mechanism. Antiproliferative effect and apoptosis induction of RCC cells and mouse osteocla...
Autores principales: | Kurabayashi, Atsushi, Inoue, Keiji, Fukuhara, Hideo, Karashima, Takashi, Fukata, Satoshi, Kawada, Chiaki, Shuin, Taro, Furihata, Mutsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556400/ https://www.ncbi.nlm.nih.gov/pubmed/26041278 http://dx.doi.org/10.1111/cas.12711 |
Ejemplares similares
-
Performance of 5-aminolevulinic-acid-based photodynamic diagnosis for radical prostatectomy
por: Fukuhara, Hideo, et al.
Publicado: (2015) -
Evaluation of a rapid one-step PSA test for primary prostate cancer screening
por: Ashida, Shingo, et al.
Publicado: (2021) -
SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression
por: Tamura, Kenji, et al.
Publicado: (2017) -
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
por: Sato, K, et al.
Publicado: (2006) -
Current status of photodynamic technology for urothelial cancer
por: Inoue, Keiji, et al.
Publicado: (2021)